Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sami Hoque

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Frontline Gastroenterology|July 12, 2021
An interesting pill to swallowKarishma Sethi, Sami Hoque
European Journal of Case Reports in Internal Medicine|October 9, 2025
Cerebral Vein Sinus Thrombosis, An Unusual Complication of Inflammatory Bowel DiseaseAhmad Yehia, Themba Mudege, Sami Hoque
Journal of Medical Case Reports|February 23, 2018
Mesalazine-induced myocarditis: a case reportShiva T Radhakrishnan, Aruchuna Mohanaruban, Sami Hoque
Frontline Gastroenterology|September 4, 2020
Masquerading in the midgut: a rare diagnosis in a patient with recurrent abdominal painPhilip J Smith, Trusha Patel, Nicholas Reading, et al.
BMJ Open Gastroenterology|February 24, 2021
Ferric maltol Real-world Effectiveness Study in Hospital practice (FRESH): clinical characteristics and outcomes of patients with inflammatory bowel disease receiving ferric maltol for iron-deficiency anaemia in the UKJr Fraser Cummings, Aileen Fraser, Catherine Stansfield, et al.
Clinicoeconomics and Outcomes Research : CEOR|March 6, 2025
Dose Escalation Patterns and Associated Costs of Advanced Therapies for Ulcerative Colitis in France and the United Kingdom: A Retrospective Database AnalysisTamás Treuer, Melissa Richards, Can Mert, et al.
Pharmacoeconomics|October 19, 2015
Vedolizumab for the Treatment of Adults with Moderate-to-Severe Active Ulcerative Colitis: An Evidence Review Group Perspective of a NICE Single Technology AppraisalMunira Essat, Paul Tappenden, Shijie Ren, et al.
BMJ Open Gastroenterology|November 17, 2020
Treatment persistence and colectomy-free outcomes in patients with ulcerative colitis receiving golimumab or adalimumab: a UK experienceSami Hoque, Amy Puenpatom, Simona Boccaletti, et al.
The Cochrane Database of Systematic Reviews|January 20, 2021
Interventions for treating iron deficiency anaemia in inflammatory bowel diseaseMorris Gordon, Vassiliki Sinopoulou, Zipporah Iheozor-Ejiofor, et al.
Frontline Gastroenterology|June 20, 2022
Artificial intelligence and inflammatory bowel disease: practicalities and future prospectsJohanne Brooks-Warburton, James Ashton, Anjan Dhar, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Frontline Gastroenterology|July 12, 2021
An interesting pill to swallowKarishma Sethi, Sami Hoque
European Journal of Case Reports in Internal Medicine|October 9, 2025
Cerebral Vein Sinus Thrombosis, An Unusual Complication of Inflammatory Bowel DiseaseAhmad Yehia, Themba Mudege, Sami Hoque
Journal of Medical Case Reports|February 23, 2018
Mesalazine-induced myocarditis: a case reportShiva T Radhakrishnan, Aruchuna Mohanaruban, Sami Hoque
Frontline Gastroenterology|September 4, 2020
Masquerading in the midgut: a rare diagnosis in a patient with recurrent abdominal painPhilip J Smith, Trusha Patel, Nicholas Reading, et al.
BMJ Open Gastroenterology|February 24, 2021
Ferric maltol Real-world Effectiveness Study in Hospital practice (FRESH): clinical characteristics and outcomes of patients with inflammatory bowel disease receiving ferric maltol for iron-deficiency anaemia in the UKJr Fraser Cummings, Aileen Fraser, Catherine Stansfield, et al.
Clinicoeconomics and Outcomes Research : CEOR|March 6, 2025
Dose Escalation Patterns and Associated Costs of Advanced Therapies for Ulcerative Colitis in France and the United Kingdom: A Retrospective Database AnalysisTamás Treuer, Melissa Richards, Can Mert, et al.
Pharmacoeconomics|October 19, 2015
Vedolizumab for the Treatment of Adults with Moderate-to-Severe Active Ulcerative Colitis: An Evidence Review Group Perspective of a NICE Single Technology AppraisalMunira Essat, Paul Tappenden, Shijie Ren, et al.
BMJ Open Gastroenterology|November 17, 2020
Treatment persistence and colectomy-free outcomes in patients with ulcerative colitis receiving golimumab or adalimumab: a UK experienceSami Hoque, Amy Puenpatom, Simona Boccaletti, et al.
The Cochrane Database of Systematic Reviews|January 20, 2021
Interventions for treating iron deficiency anaemia in inflammatory bowel diseaseMorris Gordon, Vassiliki Sinopoulou, Zipporah Iheozor-Ejiofor, et al.
Frontline Gastroenterology|June 20, 2022
Artificial intelligence and inflammatory bowel disease: practicalities and future prospectsJohanne Brooks-Warburton, James Ashton, Anjan Dhar, et al.
Pageof 2